Topic

California

A collection of 402 issues

Myths vs. Facts: Getting Naglazyme (galsulfase) Covered by UnitedHealthcare in California

Answer Box: Fast Facts for California Patients UnitedHealthcare requires prior authorization for Naglazyme (galsulfase) in California. Success depends on complete diagnostic documentation (enzyme assay + genetic testing), specialist involvement, and baseline functional assessments. If denied, California's Independent Medical Review (IMR) overturns 55-70% of medical necessity denials. First step: Have
5 min read

How to Get iLink® Corneal Cross-Linking Covered by Humana in California: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting iLink® Covered by Humana in California Yes, Humana generally covers iLink® corneal cross-linking for progressive keratoconus when medical necessity criteria are met. The fastest path to approval: 1) Verify your ophthalmologist and facility are in-network, 2) Submit prior authorization with documented progression over 12 months (≥1.0
6 min read

How to Get Eylea and Lucentis Covered by UnitedHealthcare in California: Complete Prior Authorization and Appeal Guide

Quick Answer: UnitedHealthcare requires prior authorization for Eylea (aflibercept) and Lucentis (ranibizumab) in California. Submit requests through the UnitedHealthcare Provider Portal with OCT imaging, visual acuity measurements, and diagnosis documentation. If denied, file an internal appeal within 30 days, then request a California DMHC Independent Medical Review for binding external
5 min read

Renewing Myozyme (Alglucosidase Alfa) Approval with Humana in California: Complete 2025 Guide

Answer Box: Getting Myozyme Renewal Approved Start 30-60 days early. Humana typically requires annual reauthorization for Myozyme (alglucosidase alfa) with updated clinical documentation showing ongoing benefit. Your prescriber must submit: confirmed Pompe diagnosis, recent specialist visit notes, objective response measures (6-minute walk, pulmonary function), current dosing, and safety data. If
5 min read

How Long Does It Take to Get Krystexxa (Pegloticase) Approved by Blue Cross Blue Shield California? Complete Timeline & Appeal Guide

Answer Box: Fastest Path to Krystexxa Approval in California Getting Krystexxa (pegloticase) covered by Blue Cross Blue Shield California typically takes 5-14 business days for initial prior authorization, with yearly reauthorization required. The fastest approval path requires complete documentation of allopurinol/febuxostat failure, G6PD testing, and methotrexate co-therapy plans submitted
7 min read